Comparison of the effects of rituximab, tumor necrosis factor alpha inhibitors and non-steroidal antiinflammatory drugs on ankylosing spondylitis clinical activity and sacroileitis intensity on magnetic resonance imaging
- Authors: Protopopov MS1,2, Erdes S.F1,3, Lapshina SA1, Myasoutova LI1, Zakirov RK.1,2, Afanasyeva MA2
-
Affiliations:
- Kazan State Medical University, Kazan, Russia
- Republican Clinical Hospital, Kazan, Russia
- Scientific and Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia
- Issue: Vol 94, No 6 (2013)
- Pages: 870-876
- Section: Theoretical and clinical medicine
- URL: https://journals.rcsi.science/kazanmedj/article/view/1809
- DOI: https://doi.org/10.17816/KMJ1809
- ID: 1809
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
M S Protopopov
Kazan State Medical University, Kazan, Russia; Republican Clinical Hospital, Kazan, Russia
Email: mikhailprotopopov@gmail.com
Sh F Erdes
Kazan State Medical University, Kazan, Russia; Scientific and Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia
S A Lapshina
Kazan State Medical University, Kazan, Russia
L I Myasoutova
Kazan State Medical University, Kazan, Russia
R Kh Zakirov
Kazan State Medical University, Kazan, Russia; Republican Clinical Hospital, Kazan, Russia
M A Afanasyeva
Republican Clinical Hospital, Kazan, Russia
References
- Насонов Е.Л. Ревматология: Клинические рекомендации. - М.: ГЭОТАР-Медиа, 2010. - 752 с.
- Поддубный Д.А., Ребров А.П., Морова О.Л. Валидация шкал оценки активности заболевания и функционального состояния при болезни Бехтерева // Клин. мед. - 2007. - №4. - С. 40-45.
- Braun J., Bollow M., Neure L. et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis // Arthr. Rheum. - 1995. - Vol. 38, N 4. - P. 499-505.
- Braun J., van den Berg R., Baraliakos X. et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis // Ann. Rheum. Dis. - 2011. - Vol. 70. - P. 896-904.
- Lukas C., Landewé R., Sieper J. et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis // Ann. Rheum. Dis. - 2009. - Vol. 68. - P. 18-24.
- Machado M.A., Barbosa M.M., Almeida A.M. Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis // Rheumatol. Int. - 2013. - Vol. 33, N 9. - P. 2199-2213.
- Maksymowych W.P., Inman R.D., Salonen D. et al. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis // Arthritis Rheum. - 2005. - Vol. 53, N 5. - P. 703-709.
- Poddubnyy D. Axial spondyloarthritis: is there a treatment of choice? // Ther. Adv. Musculoskel. Dis. - 2013. - Vol. 5, N 1. - P. 45-54.
- Sieper J., Rudwaleit M., Baraliakos X. et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis // Ann. Rheum. Dis. - 2009. - Vol. 68. -P. ii1-ii44.
- Song I.H., Heldmann F., Rudwaleit M. et al. Different response to rituximab in tumor necrosis factor blocker - naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed // Arthritis Rheum. - 2010. - Vol. 62, N 5. - P. 1290-1297.
- Tracey D., Klareskog L., Sasso E.H. et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review // Pharmacol. Ther. - 2008. - Vol. 17. - P. 244-279.
- Van der Linden S.M., Valkenburg H.A., Cats A. Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria // Arthritis Rheum. - 1984. - Vol. 27. - P. 361-368.
- Vincent F.B., Morand E.F., Murphy K. et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF) - specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective // Ann. Rheum. Dis. - 2013. - Vol. 72, N 2. - P. 165-178.
- Wanders A., Heijde D., Landewe R. et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial // Arthritis Rheum. - 2005. - Vol. 52. - P. 1756-1765.
- Wendling D., Dougados M., Berenbaum F. et al. Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology // J. Rheumatol. - 2012. - Vol. 39, N 12. - P. 2327-2331.